VSee Health completes sale of VSee Lab to ex-co-CEO Milton Chen

VSee Health

VSee Health

VSEE

0.00

  • VSee Health sold 100% of VSee Lab to former co-CEO and chairman Milton Chen under a stock purchase agreement dated May 31, 2026.
  • Chen transferred 2,870,069 VSee Health common shares back to the company, representing about 7% of outstanding stock, for retirement.
  • Chen assumed responsibility for VSee Lab’s remaining liabilities following closing, removing the lab unit from VSee Health’s structure.
  • The deal leaves VSee Health focused on its iDoc telehealth platform and enterprise digital health offerings.
  • Leadership shifted to a single CEO as Chen resigned; Imoigele Aisiku became sole CEO and board chairman.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606110830ACCESSWRNAPR_____1175990) on June 11, 2026, and is solely responsible for the information contained therein.